PANCREATIC CANCER BORDERLINE
Clinical trials for PANCREATIC CANCER BORDERLINE explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC CANCER BORDERLINE trials appear
Sign up with your email to follow new studies for PANCREATIC CANCER BORDERLINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Light-Activated therapy targets pancreatic tumors during surgery
Disease control Not yet recruitingThis study tests a new approach called photoimmunotherapy for people with locally advanced or borderline resectable pancreatic cancer. Patients receive an injection of ASP-1929, a drug that attaches to cancer cells and becomes active when exposed to a specific light. During surge…
Matched conditions: PANCREATIC CANCER BORDERLINE
Phase: PHASE1, PHASE2 • Sponsor: Brown University • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New study aims to reduce dangerous clots after complex pancreatic surgery
Knowledge-focused Not yet recruitingThis study looks at why some patients develop blood clots after pancreatic surgery that also involves removing a piece of a major vein. Researchers will collect information from over 1,000 patients across many hospitals to see how surgical techniques and blood-thinning medication…
Matched conditions: PANCREATIC CANCER BORDERLINE
Sponsor: Sahlgrenska University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC